Shandong Provincial Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 2022-03-18

Employees: -

Market Cap: -

Website: http://www.sph.com.cn

Clinical Trials

Endocrine Glucose & Lipids Metabolism and Brain Aging: a Longitudinal Study

Recruiting

Conditions: Brain Aging Related Conditions

First Posted Date: 2023-10-04

Last Posted Date: 2023-10-06

Lead Sponsor: Shandong Provincial Hospital

Target Recruit Count: 10000

Registration Number: NCT06066775

Locations: 🇨🇳
Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis

Not Applicable

Active, not recruiting

Conditions: Chronic Atrophic Gastritis

Interventions: Biological: Mononuclear cells
Drug: Weifuchun+Hydrotalcite/L-Glutamine and Sodium Gualenate Granules

First Posted Date: 2023-04-11

Last Posted Date: 2024-04-17

Lead Sponsor: Shandong Provincial Hospital

Target Recruit Count: 60

Registration Number: NCT05808010

Locations: 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China

A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection

Phase 4

Recruiting

Conditions: COVID-19

Interventions: Drug: Azvudine
Drug: Nirmatrelvir-Ritonavir

First Posted Date: 2023-01-25

Last Posted Date: 2023-02-27

Lead Sponsor: Shandong Provincial Hospital

Target Recruit Count: 410

Registration Number: NCT05697055

Locations: 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China

Association Between Multiple Coagulation-related Factors and Lymph Node Metastasis in Patients With Gastric Cancer: A Retrospective Cohort Study

Recruiting

Conditions: Lymph Node Metastasis
Gastric Cancer Stage

Interventions: Diagnostic Test: coagulation-related factors

First Posted Date: 2022-10-25

Last Posted Date: 2022-10-25

Lead Sponsor: Shandong Provincial Hospital

Target Recruit Count: 516

Registration Number: NCT05592925

Locations: 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China

High-power Green-light Laser Endoscopic Submucosal Dissection for Non-muscle-invasive Bladder Cancer

Completed

Conditions: Bladder Cancer

First Posted Date: 2022-03-22

Last Posted Date: 2022-03-22

Lead Sponsor: Shandong Provincial Hospital

Target Recruit Count: 45

Registration Number: NCT05290623

Locations: 🇨🇳
Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Phase 3

Recruiting

Conditions: Mantle Cell Lymphoma
High Grade B-Cell Lymphoma, Not Otherwise Specified
High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
Diffuse Large B Cell Lymphoma
B-cell Non Hodgkin Lymphoma

Interventions: Drug: Zanubrutinib+R-CHOP; Zanubrutinib+R-DA-EPOCH; Zanubrutinib+R-HD MTX
Drug: R-CHOP; R-DA-EPOCH; R-HD MTX

First Posted Date: 2021-12-21

Last Posted Date: 2021-12-21

Lead Sponsor: Shandong Provincial Hospital

Target Recruit Count: 160

Registration Number: NCT05164770

Locations: 🇨🇳
Department of Hematology, Shandong Provincial Hospital, Jinan, Shandong, China

Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Phase 3

Recruiting

Conditions: High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
Mantle Cell Lymphoma
B-cell NonHodgkin Lymphoma
High Grade B-Cell Lymphoma, Not Otherwise Specified
Diffuse Large B-cell Lymphoma

Interventions: Drug: Orelabrutinib+R-CHOP; Orelabrutinib+R-DA-EPOCH; Orelabrutinib+R-HD MTX;Orelabrutinib+R+other chemotherapies

First Posted Date: 2021-10-28

Last Posted Date: 2021-11-19

Lead Sponsor: Shandong Provincial Hospital

Target Recruit Count: 130

Registration Number: NCT05097443

Locations: 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China

HBOT in the Treatment and Prevention of aGVHD

Not Applicable

Recruiting

Conditions: Acute-graft-versus-host Disease
Hyperbaric Oxygen Therapy

Interventions: Device: Hyperbaric oxygen therapy

First Posted Date: 2021-10-14

Last Posted Date: 2021-10-14

Lead Sponsor: Shandong Provincial Hospital

Target Recruit Count: 100

Registration Number: NCT05078073

Locations: 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China

Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors

Phase 4

Conditions: Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease

Interventions: Drug: Micafungin Sodium

First Posted Date: 2021-02-04

Last Posted Date: 2021-02-04

Lead Sponsor: Shandong Provincial Hospital

Target Recruit Count: 230

Registration Number: NCT04738955

Locations: 🇨🇳
Department of Hematology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China

Hyperbaric Oxygen Therapy for Hemorrhagic Cystitis Post HSCT

Not Applicable

Recruiting

Conditions: Stem Cell Transplant Complications

Interventions: Procedure: Hyperbaric oxygen therapy

First Posted Date: 2020-08-06

Last Posted Date: 2021-09-08

Lead Sponsor: Shandong Provincial Hospital

Target Recruit Count: 150

Registration Number: NCT04502628

Locations: 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy